A review of the performance of urinary cytology with a focus on atypia, upper tract and updates on novel ancillary testing
- 19 September 2024
- journal article
- review article
- Published by Elsevier in Journal of the American Society of Cytopathology
- Vol. 14 (1) , 23-35
Abstract
No abstract availableKeywords
This publication has 109 references indexed in Scilit:
- Acu‐URO17 is a highly sensitive and specific bladder cancer biomarkerBJUI Compass, 2024
- A deep learning system to diagnose the malignant potential of urothelial carcinoma cells in cytology specimensCancer Cytopathology, 2021
- Significant reduction of indeterminate (atypical) diagnosis after implementation of The Paris System for Reporting Urinary Cytology: A single‐institution study of more than 27,000 casesCancer Cytopathology, 2020
- A review of upper urinary tract cytology performance before and after the implementation of The Paris SystemCancer Cytopathology, 2020
- Performance of an artificial intelligence algorithm for reporting urine cytopathologyCancer Cytopathology, 2019
- Automating the Paris System for urine cytopathology—A hybrid deep‐learning and morphometric approachCancer Cytopathology, 2019
- A 20‐year and 46,000‐specimen journey to Paris reveals the influence of reporting systems and passive peer feedback on pathologist practice patternsCancer Cytopathology, 2018
- One year of experience using the Paris System for Reporting Urinary CytologyCancer Cytopathology, 2018
- Implementing The Paris System for Reporting Urinary Cytology results in a decrease in the rate of the “atypical” category and an increase in its prediction of subsequent high‐grade urothelial carcinomaCancer Cytopathology, 2017
- Young investigator challenge: The accuracy of the nuclear‐to‐cytoplasmic ratio estimation among trained morphologistsCancer Cytopathology, 2015